CCL2 and neoplasm: We propose a model in which (1) CCL2 stimulates EPC development in the marrow, (2) mammary carcinomas mobilize EPCs in a CCL2-dependent manner, and (3) EPC migration into tumors is mediated by other factors such as VEGF which rises in the serum of tumor-bearing mice.